PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29394038
OWN - NLM
STAT- MEDLINE
DCOM- 20180205
LR  - 20180207
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Linking)
VI  - 378
IP  - 5
DP  - 2018 Feb 1
TI  - Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
PG  - 484-5
LID - 10.1056/NEJMc1715183 [doi]
FAU - Dekkers, Tanja
AU  - Dekkers T
AD  - Canisius Wilhemina Ziekenhuis, Nijmegen, the Netherlands
FAU - Lafeber, Melvin
AU  - Lafeber M
AD  - University Medical Center Utrecht, Utrecht, the Netherlands
FAU - Kramers, Cornelis
AU  - Kramers C
AD  - Radboud University Medical Center, Nijmegen, the Netherlands
      [email protected]
LA  - eng
PT  - Letter
PT  - Comment
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Anticoagulants)
RN  - 0 (Fibrinolytic Agents)
RN  - 5Q7ZVV76EI (Warfarin)
RN  - I0VM4M70GC (Dabigatran)
SB  - AIM
SB  - IM
CON - N Engl J Med. 2017 Oct 19;377(16):1513-1524. PMID: 28844193
CIN - N Engl J Med. 2018 Feb 1;378(5):484-486. PMID: 29385366
MH  - Anticoagulants
MH  - *Atrial Fibrillation
MH  - *Dabigatran
MH  - Fibrinolytic Agents
MH  - Humans
MH  - Percutaneous Coronary Intervention
MH  - Stroke
MH  - Warfarin
EDAT- 2018/02/03 06:00
MHDA- 2018/02/06 06:00
CRDT- 2018/02/03 06:00
PHST- 2018/02/03 06:00 [entrez]
PHST- 2018/02/03 06:00 [pubmed]
PHST- 2018/02/06 06:00 [medline]
AID - 10.1056/NEJMc1715183#SA2 [pii]
AID - 10.1056/NEJMc1715183 [doi]
PST - ppublish
SO  - N Engl J Med. 2018 Feb 1;378(5):484-5. doi: 10.1056/NEJMc1715183.